関連レポート

出版元：Transparency Market Research  出版元について

発行年：2024年7月

定価：Single User License $5795 Multi User License $8795 Corporate User License $11795

ご請求は円換算（お見積り日TTSレート）となります。

ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。

納品形態：PDF by Email

当調査レポートは英文 113ページになります。

商品コード：TMR315

当レポートは発行年月に関わらず、受注の都度、最新情報にアップデートしてお届けいたします。ご希望情報の追加等もご相談可能です。

レポート紹介

医療用バイオミメティクス(生物模倣）の世界市場規模は2023年で94億ドル、2034年に193億ドル、市場の平均年成長率は6.8%にて増加する見込みです。

当レポートでは、医療用バイオミメティクス(生物模倣）の市場予測-2034年、各種セグメント別市場分析(適応疾患別、用途別、国地域別、等)、パイプライン分析、主要製品/ブランド分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】
■医療用バイオミメティクス(生物模倣）の世界市場予測2020-2034年
・市場規模(US$)

■適応疾患別、市場-2034年
・循環器科
・整形外科
・眼科
・歯科
・その他（再生医療など）
※(市場規模US$)

■用途別、市場-2034年
・創傷治癒
・ドラッグデリバリー
・組織工学
※(市場規模US$)　

■エンドユーザー別、市場-2034年
・病院
・専門クリニック
・外来外科クリニック
・その他（学術、研究機関など）
※(市場規模US$)　

■主要国地域別市場-2034年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照

■市場分析
市場ダイナミクス
パイプライン分析
主要製品/ブランド分析
主要な合併、買収

■医療用バイオミメティクス(生物模倣）の主要企業プロフィール動向
LifeMatrix Technologies AG
大塚ホールディングス株式会社
CorNeat Vision
Alcon Inc.
vVardis AG
Mimetis Biomaterials
Stryker Tech
Osteopore International
Avery Therapeutics, Inc.
Prellis Biologics
Lattice Medical
（全113頁）

Table of Contents (英文詳細目次）

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Medical Biomimetics Market

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Medical Biomimetics Market Analysis and Forecast, 2020-2034

5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Medical Biomimetics Market Analysis and Forecast, by Disease Indication
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Disease Indication, 2020-2034
6.3.1. Cardiovascular
6.3.2. Orthopedics
6.3.3. Ocular
6.3.4. Dental
6.3.5. Others (Regenerative Medicine, etc.)
6.4. Market Attractiveness Analysis, by Disease Indication

7. Global Medical Biomimetics Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2020-2034
7.3.1. Wound Healing
7.3.2. Drug Delivery
7.3.3. Tissue Engineering
7.4. Market Attractiveness Analysis, by Application

8. Global Medical Biomimetics Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Ambulatory Surgery Clinics
8.3.4. Others (Academic and Research Institutes, etc.)
8.4. Market Attractiveness Analysis, by End-user

9. Global Medical Biomimetics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region

10. North America Medical Biomimetics Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Disease Indication, 2020-2034
10.3.1. Cardiovascular
10.3.2. Orthopedics
10.3.3. Ocular
10.3.4. Dental
10.3.5. Others (Regenerative Medicine, etc.)
10.4. Market Value Forecast, by Application, 2020-2034
10.4.1. Wound Healing
10.4.2. Drug Delivery
10.4.3. Tissue Engineering
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Hospitals
10.5.2. Specialty Clinics
10.5.3. Ambulatory Surgery Clinics
10.5.4. Others (Academic and Research Institutes, etc.)
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Disease Indication
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country

11. Europe Medical Biomimetics Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Disease Indication, 2020-2034
11.3.1. Cardiovascular
11.3.2. Orthopedics
11.3.3. Ocular
11.3.4. Dental
11.3.5. Others (Regenerative Medicine, etc.)
11.4. Market Value Forecast, by Application, 2020-2034
11.4.1. Wound Healing
11.4.2. Drug Delivery
11.4.3. Tissue Engineering
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Hospitals
11.5.2. Specialty Clinics
11.5.3. Ambulatory Surgery Clinics
11.5.4. Others (Academic and Research Institutes, etc.)
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Disease Indication
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region

12. Asia Pacific Medical Biomimetics Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Disease Indication, 2020-2034
12.3.1. Cardiovascular
12.3.2. Orthopedics
12.3.3. Ocular
12.3.4. Dental
12.3.5. Others (Regenerative Medicine, etc.)
12.4. Market Value Forecast, by Application, 2020-2034
12.4.1. Wound Healing
12.4.2. Drug Delivery
12.4.3. Tissue Engineering
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Hospitals
12.5.2. Specialty Clinics
12.5.3. Ambulatory Surgery Clinics
12.5.4. Others (Academic and Research Institutes, etc.)
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Disease Indication
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region

13. Latin America Medical Biomimetics Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Disease Indication, 2020-2034
13.3.1. Cardiovascular
13.3.2. Orthopedics
13.3.3. Ocular
13.3.4. Dental
13.3.5. Others (Regenerative Medicine, etc.)
13.4. Market Value Forecast, by Application, 2020-2034
13.4.1. Wound Healing
13.4.2. Drug Delivery
13.4.3. Tissue Engineering
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Hospitals
13.5.2. Specialty Clinics
13.5.3. Ambulatory Surgery Clinics
13.5.4. Others (Academic and Research Institutes, etc.)
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Disease Indication
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region

14. Middle East & Africa Medical Biomimetics Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Disease Indication, 2020-2034
14.3.1. Cardiovascular
14.3.2. Orthopedics
14.3.3. Ocular
14.3.4. Dental
14.3.5. Others (Regenerative Medicine, etc.)
14.4. Market Value Forecast, by Application, 2020-2034
14.4.1. Wound Healing
14.4.2. Drug Delivery
14.4.3. Tissue Engineering
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Hospitals
14.5.2. Specialty Clinics
14.5.3. Ambulatory Surgery Clinics
14.5.4. Others (Academic and Research Institutes, etc.)
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Disease Indication
14.7.2. By Application
14.7.3. By End-user
14.7.4. By Country/Sub-region

15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. LifeMatrix Technologies AG
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Otsuka Holdings Co., Ltd.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. CorNeat Vision
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Alcon Inc.
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. vVardis AG
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Mimetis Biomaterials
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Stryker Tech
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Osteopore International
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Avery Therapeutics, Inc.
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Prellis Biologics
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Lattice Medical
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview

List of Tables

Table 01: Global Medical Biomimetics Market Size (US$ Mn) Forecast, by Disease Indication, 2020-2034

Table 02: Global Medical Biomimetics Market Size (US$ Mn) Forecast, by Application, 2020-2034

Table 03: Global Medical Biomimetics Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 04: Global Medical Biomimetics Market Size (US$ Mn) Forecast, by Region, 2020-2034

Table 05: North America Medical Biomimetics Market Size (US$ Mn) Forecast, by Country, 2020-2034

Table 06: North America Medical Biomimetics Market Size (US$ Mn) Forecast, by Disease Indication, 2020-2034

Table 07: North America Medical Biomimetics Market Size (US$ Mn) Forecast, by Application, 2020-2034

Table 08: North America Medical Biomimetics Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 09: Europe Medical Biomimetics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 10: Europe Medical Biomimetics Market Size (US$ Mn) Forecast, by Disease Indication, 2020-2034

Table 11: Europe Medical Biomimetics Market Size (US$ Mn) Forecast, by Application, 2020-2034

Table 12: Europe Medical Biomimetics Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 13: Asia Pacific Medical Biomimetics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 14: Asia Pacific Medical Biomimetics Market Size (US$ Mn) Forecast, by Disease Indication, 2020-2034

Table 15: Asia Pacific Medical Biomimetics Market Size (US$ Mn) Forecast, by Application, 2020-2034

Table 16: Asia Pacific Medical Biomimetics Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 17: Latin America Medical Biomimetics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 18: Latin America Medical Biomimetics Market Size (US$ Mn) Forecast, by Disease Indication, 2020-2034

Table 19: Latin America Medical Biomimetics Market Size (US$ Mn) Forecast, by Application, 2020-2034

Table 20: Latin America Medical Biomimetics Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 21: Middle East & Africa Medical Biomimetics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 22: Middle East & Africa Medical Biomimetics Market Size (US$ Mn) Forecast, by Disease Indication, 2020-2034

Table 23: Middle East & Africa Medical Biomimetics Market Size (US$ Mn) Forecast, by Application, 2020-2034

Table 24: Middle East & Africa Medical Biomimetics Market Size (US$ Mn) Forecast, by End-user, 2020-2034

List of Figures

Figure 01: Global Medical Biomimetics Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034

Figure 02: Global Medical Biomimetics Market Revenue (US$ Mn), by Disease Indication, 2023

Figure 03: Global Medical Biomimetics Market Value Share, by Disease Indication, 2023

Figure 04: Global Medical Biomimetics Market Revenue (US$ Mn), by Application, 2023

Figure 05: Global Medical Biomimetics Market Value Share, by Application, 2023

Figure 06: Global Medical Biomimetics Market Revenue (US$ Mn), by End-user, 2023

Figure 07: Global Medical Biomimetics Market Value Share, by End-user, 2023

Figure 08: Global Medical Biomimetics Market Value Share, by Region, 2023

Figure 09: Global Medical Biomimetics Market Value (US$ Mn) Forecast, 2020-2034

Figure 10: Global Medical Biomimetics Market Value Share Analysis, by Disease Indication, 2023 and 2034

Figure 11: Global Medical Biomimetics Market Attractiveness Analysis, by Region, 2024-2034

Figure 12: Global Medical Biomimetics Market Value Share Analysis, by Application, 2023 and 2034

Figure 13: Global Medical Biomimetics Market Attractiveness Analysis, by Application, 2024-2034

Figure 14: Global Medical Biomimetics Market Value Share Analysis, by End-user, 2023 and 2034

Figure 15: Global Medical Biomimetics Market Attractiveness Analysis, by End-user, 2024-2034

Figure 16: Global Medical Biomimetics Market Value Share Analysis, by Region, 2023 and 2034

Figure 17: Global Medical Biomimetics Market Attractiveness Analysis, by Region, 2024-2034

Figure 18: North America Medical Biomimetics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 19: North America Medical Biomimetics Market Attractiveness Analysis, by Country, 2024-2034

Figure 20: North America Medical Biomimetics Market Value Share Analysis, by Country, 2023 and 2034

Figure 21: North America Medical Biomimetics Market Value Share Analysis, by Disease Indication, 2023 and 2034

Figure 22: North America Medical Biomimetics Market Value Share Analysis, by Application, 2023 and 2034

Figure 23: North America Medical Biomimetics Market Value Share Analysis, by End-user, 2023 and 2034

Figure 24: North America Medical Biomimetics Market Attractiveness Analysis, by Region, 2024-2034

Figure 25: North America Medical Biomimetics Market Attractiveness Analysis, by Application, 2024-2034

Figure 26: North America Medical Biomimetics Market Attractiveness Analysis, by End-user, 2024-2034

Figure 27: Europe Medical Biomimetics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 28: Europe Medical Biomimetics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 29: Europe Medical Biomimetics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 30: Europe Medical Biomimetics Market Value Share Analysis, by Disease Indication, 2023 and 2034

Figure 31: Europe Medical Biomimetics Market Value Share Analysis, by Application, 2023 and 2034

Figure 32: Europe Medical Biomimetics Market Value Share Analysis, by End-user, 2023 and 2034

Figure 33: Europe Medical Biomimetics Market Attractiveness Analysis, by Region, 2024-2034

Figure 34: Europe Medical Biomimetics Market Attractiveness Analysis, by Application, 2024-2034

Figure 35: Europe Medical Biomimetics Market Attractiveness Analysis, by End-user, 2024-2034

Figure 36: Asia Pacific Medical Biomimetics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 37: Asia Pacific Medical Biomimetics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 38: Asia Pacific Medical Biomimetics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 39: Asia Pacific Medical Biomimetics Market Value Share Analysis, by Disease Indication, 2023 and 2034

Figure 40: Asia Pacific Medical Biomimetics Market Value Share Analysis, by Application, 2023 and 2034

Figure 41: Asia Pacific Medical Biomimetics Market Value Share Analysis, by End-user, 2023 and 2034

Figure 42: Asia Pacific Medical Biomimetics Market Attractiveness Analysis, by Region, 2024-2034

Figure 43: Asia Pacific Medical Biomimetics Market Attractiveness Analysis, by Application, 2024-2034

Figure 44: Asia Pacific Medical Biomimetics Market Attractiveness Analysis, by End-user, 2024-2034

Figure 45: Latin America Medical Biomimetics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 46: Latin America Medical Biomimetics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 47: Latin America Medical Biomimetics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 48: Latin America Medical Biomimetics Market Value Share Analysis, by Disease Indication, 2023 and 2034

Figure 49: Latin America Medical Biomimetics Market Value Share Analysis, by Application, 2023 and 2034

Figure 50: Latin America Medical Biomimetics Market Value Share Analysis, by End-user, 2023 and 2034

Figure 51: Latin America Medical Biomimetics Market Attractiveness Analysis, by Region, 2024-2034

Figure 52: Latin America Medical Biomimetics Market Attractiveness Analysis, by Application, 2024-2034

Figure 53: Latin America Medical Biomimetics Market Attractiveness Analysis, by End-user, 2024-2034

Figure 54: Middle East & Africa Medical Biomimetics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 55: Middle East & Africa Medical Biomimetics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 56: Middle East & Africa Medical Biomimetics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 57: Middle East & Africa Medical Biomimetics Market Value Share Analysis, by Disease Indication, 2023 and 2034

Figure 58: Middle East & Africa Medical Biomimetics Market Value Share Analysis, by Application, 2023 and 2034

Figure 59: Middle East & Africa Medical Biomimetics Market Value Share Analysis, by End-user, 2023 and 2034

Figure 60: Middle East & Africa Medical Biomimetics Market Attractiveness Analysis, by Region, 2024-2034

Figure 61: Middle East & Africa Medical Biomimetics Market Attractiveness Analysis, by Application, 2024-2034

Figure 62: Middle East & Africa Medical Biomimetics Market Attractiveness Analysis, by End-user, 2024-2034

△ 一番上に戻る